Clinical Trials
51 trialsEvaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Memorial Sloan Kettering Cancer Center
First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
Masonic Cancer Center, University of Minnesota
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients
St. Jude Children's Research Hospital
DANNIgene
Assistance Publique - Hôpitaux de Paris
Ultralow Dose PET Imaging of 18F-FDOPA
Nuclear Imaging Institute
BIChE-1
University Hospital, Angers
MRI in High-Grade Glioma Patients Undergoing Chemoradiation
Wake Forest University Health Sciences
Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance
Wake Forest University Health Sciences
A Study to Evaluate the Safety and Efficacy of Intracranial Venous Blood Sampling for Liquid Biopsy in the Diagnosis of Brain Cancers
M.D. Anderson Cancer Center
Andro-iGlio
Assistance Publique - Hôpitaux de Paris
IMMUNEORGANOID
Gustave Roussy, Cancer Campus, Grand Paris
BIOLIMEN-1
University Hospital, Montpellier
MM-Predict
Assistance Publique Hopitaux De Marseille
BRICCS
Mayo Clinic
EPIGLIO
Institut du Cancer de Montpellier - Val d'Aurelle
GLIOMIT
Centre Hospitalier Universitaire, Amiens
PROGLIO
Centre Jean Perrin
Assessing Brain Metabolism Using MRS With Deuterated Glucose
University of California, San Francisco
Imaging of Solid Tumors Using 18F-TRX
University of California, San Francisco
GLIOLIPSY
University Hospital, Montpellier
Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
IRCCS San Raffaele
Glutamate Excitotoxicity and Its Role in Glioblastoma Biology
IRCCS San Raffaele
Evaluating Mitochondrial Dysfunction in Patients With Neurofibromatosis Type 1
University of Arkansas
ALCINA2
Institut du Cancer de Montpellier - Val d'Aurelle
BZKF-AYA
University Hospital Regensburg
BOOSTCAR
Central Hospital, Nancy, France
ExoGLIE
University Hospital, Limoges
HEPHESTOS
Radboud University Medical Center
GLIBAMIR
University Hospital, Caen
ALTREM
Assistance Publique Hopitaux De Marseille
GliomiR
University Hospital, Caen
PHRCNB07
Institut Curie
Bioenergetic Profiling and Cognition in GBM Patients
Wake Forest University Health Sciences
Study of the Safety and Efficacy of Humanized 3F8 Bispecific Antibody (Hu3F8-BsAb) in Patients With Relapsed/Refractory Neuroblastoma, Osteosarcoma and Other Solid Tumor Cancers
Y-mAbs Therapeutics
FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Immunophenotyping From Blood of Patients With Malignant Gliomas
University of Erlangen-Nürnberg Medical School
Explor-AVD
Hopital Foch
PLANET
Centre Leon Berard
ONCOPRO
Hospices Civils de Lyon
Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters
Lund University Hospital
Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma
University of Michigan Rogel Cancer Center
GLIOMANOID
Assistance Publique Hopitaux De Marseille
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
MARELLE01
Assistance Publique Hopitaux De Marseille
Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Gliomstudien
Haukeland University Hospital
Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1
Turku University Hospital
APG101 in Glioblastoma
Apogenix AG
Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins